What Happened to Peptide Sciences? Alternatives for Researchers (2026)

# What Happened to Peptide Sciences? Alternatives for Researchers (2026)

On March 6, 2026, Peptide Sciences — one of the most recognized names in the US research peptide market — quietly closed its doors. No advance warning. No refund process. Just a brief message confirming voluntary closure and a thank-you to customers.

For researchers who had relied on Peptide Sciences as a trusted source for years, the shutdown created an immediate and disorienting problem: where to go next? This guide covers the full picture — the history and reputation of Peptide Sciences, what caused the closure, what the regulatory environment looks like now, and how to systematically identify and evaluate verified alternatives using data and tools available on Peptides.SO.

For research purposes only. All peptides discussed are research chemicals, not approved for human use.

---

What Was Peptide Sciences?

Peptide Sciences (PeptideSciences.com) was a US-based research peptide supplier that operated for roughly a decade before its abrupt closure in 2026. The company built one of the strongest reputations in the domestic research peptide market, and its closure left a significant gap that the research community is still navigating.

Reputation and Standing

For much of its operating history, Peptide Sciences was considered a benchmark supplier — one that newer vendors were compared against. The reasons were concrete:

• •Broad catalog: Peptide Sciences stocked a wide variety of research peptides across multiple categories: growth hormone secretagogues (CJC-1295, Ipamorelin, GHRP-2, GHRP-6), melanocortin peptides (Melanotan II, PT-141), GLP-1 analogs (Semaglutide, Tirzepatide, Retatrutide), tissue repair compounds (BPC-157, TB-500), and nootropic peptides (Selank, Semax).
• •Domestic fulfillment: Operating from within the United States, the company offered faster shipping than international suppliers and was subject to domestic regulatory accountability.
• •Community trust built over years: On r/Peptides, Eroids, and related research forums, Peptide Sciences was consistently cited as a reliable mid-to-premium tier option. This multi-year community track record is rare and difficult to replicate — most of the US market's newer entrants lack equivalent longitudinal data.
• •Certificate of Analysis practices: For much of its operating history, Peptide Sciences provided independent third-party COA documentation for its products, including HPLC purity data.

Scale and Market Position

According to e-commerce analytics firm Grips Intelligence, Peptide Sciences was generating approximately $7.4 million in monthly online sales as recently as December 2025. This placed it among the top two or three US research peptide suppliers by revenue — a scale that means its closure affected thousands of active researchers and created a supply vacuum that no single replacement has yet filled.

---

The Peptide Sciences Shutdown — What Actually Happened

Peptide Sciences shut down voluntarily on March 6, 2026. The company issued no detailed public explanation — only a brief farewell message thanking customers for their support over the years. There was no forwarding address, no stated rationale, and no formal process for pending orders or refunds.

The shutdown was abrupt even by industry standards. Companies at Peptide Sciences' revenue scale typically provide some wind-down notice, especially for pending orders. The lack of any transition guidance left researchers scrambling and generated significant community discussion about both the cause and the legitimacy of any remaining inventory.

The Regulatory Backdrop

While Peptide Sciences offered no public statement on causation, the closure occurred against a backdrop of intensifying regulatory pressure that had been building throughout 2025:

• •FDA warning letters were issued to multiple research peptide vendors in the 12 months prior to the shutdown, including Prime Peptides, Xcel Peptides, SwissChems, and Summit Research.
• •An FDA warehouse raid targeted Amino Asylum's operations, making it the most dramatic enforcement action in the market's recent history.
• •50+ warning letters were sent to GLP-1 compounders and manufacturers over the same period, reflecting the FDA's specific focus on semaglutide and tirzepatide analogs sold as research chemicals.
• •New 2026 legislation explicitly prohibited the sale of research chemicals that are chemically identical to FDA-approved drugs without a valid NDA (New Drug Application). This legislation directly impacted suppliers whose catalogs included GLP-1 analogs — a category that had become a significant revenue driver for many vendors.

The regulatory focus on GLP-1 analogs is particularly relevant because Peptide Sciences was among the suppliers with visible inventory of these compounds. Whether regulatory pressure was the direct trigger for the closure remains unconfirmed publicly, but the timing and market context make this the most plausible explanation among researchers tracking the industry.

Quality Concerns Prior to Closure

Independent third-party testing data showed quality issues with some Peptide Sciences products in the months before the shutdown. Retatrutide, for example, received a poor quality rating based on 37 samples tested between December 2024 and March 2026, with a counterfeit detection flagged among samples in November 2025. These findings reinforced a broader industry pattern: even established suppliers experience quality control degradation, and independent third-party testing is the only reliable check.

Beware of Impersonators

Following the shutdown, confirmed reports emerged of scam sites operating under the Peptide Sciences name or branding. Do not enter payment information on any site claiming to be Peptide Sciences. The original company confirmed on March 6, 2026 that any further sales under its brand are fraudulent. Verify any unfamiliar vendor through independent community sources before purchasing anything.

---

Why Researchers Need a Diversified Approach

The Peptide Sciences closure illustrates a systemic risk that all researchers relying on a single supplier face: no vendor — regardless of track record or revenue scale — is immune to sudden shutdown.

A resilient procurement approach for 2026 includes:

1. Primary + backup suppliers: Identify at least two verified vendors who carry your most-used compounds. Cross-verify their quality records independently before you need them.

2. Staggered purchasing: Don't wait until you've depleted existing stock to source from a new supplier. Ordering early lets you evaluate quality under controlled conditions rather than under pressure.

3. Community intelligence monitoring: Track r/Peptides, research forums, and Peptides.SO reviews for early warning signals. Quality complaints, delayed shipments, and sudden product removals from a supplier's catalog often precede larger operational problems by weeks or months.

4. Independent third-party testing for new suppliers: Budget for HPLC testing on at least the first batch from any new vendor. At $100-200 per compound, this cost is minor compared to the research integrity at stake.

5. Documentation habits: Maintain COA records for every batch purchased. If a supplier closes abruptly, these records support research continuity and integrity verification.

The researchers who navigated the Peptide Sciences closure most effectively were those who already had secondary supplier relationships and current COA documentation — not those scrambling to evaluate unknown vendors at the moment their primary source went dark.

---

Best Peptide Sciences Alternatives in 2026

The following suppliers have established verification records and are actively reviewed on Peptides.SO. This is a starting point for due diligence — not an endorsement. Rankings are based on community track record, testing documentation, and operational history.

1. Paramount Peptides — Most Established US Supplier

Paramount Peptides has operated for over 12 years, making it one of the longest-standing US research peptide vendors. For researchers who identified operational stability as the key lesson from the Peptide Sciences closure, Paramount's multi-year track record is its primary differentiator.

• •Testing: Independent third-party COA per batch, HPLC + MS confirmation
• •Catalog: Broad coverage including growth hormone peptides, BPC-157, melanocortins, and GLP-1 adjacent compounds
• •Shipping: Domestic US fulfillment with cold-chain options for temperature-sensitive compounds
• •Community track record: Consistently positive across r/Peptides over multiple years
• •Read the full review: Paramount Peptides Review 2026

2. Core Peptides — Consistent Quality Data

Core Peptides has developed a strong quality track record based on independent testing data aggregated on Peptides.SO. The company's commitment to transparent per-batch COA documentation is a meaningful differentiator in a market where supplier-issued testing data is common but independent verification is not.

• •Testing: ISO/IEC 17025 accredited labs, HPLC purity data per batch with mass spectrometry confirmation
• •Catalog: Strong coverage of growth hormone secretagogues, nootropic peptides, and tissue repair compounds
• •Pricing: Mid-range, competitive for verified quality
• •Read the full review: Core Peptides Review 2026

3. Direct Peptides US — Best for Domestic Speed

For researchers who prioritize turnaround time, Direct Peptides US offers rapid domestic fulfillment with a broad catalog. Domestic warehousing eliminates international shipping delays, customs complications, and the cold-chain integrity risks of long transit times.

• •Shipping: 1-3 business day domestic fulfillment with tracking
• •Testing: Third-party COA available per batch
• •Catalog: Broad selection with frequent restocking
• •Read the full review: Direct Peptides US Review 2026

4. PureRawz — Price-Competitive with Documented Testing

PureRawz has built a substantial presence in the US research market with competitive pricing and consistent independent testing records. For researchers balancing budget constraints with quality requirements, PureRawz offers a reasonable middle ground.

• •Testing: Third-party COA, HPLC purity data
• •Catalog: Extensive, including several compounds that were heavily purchased at Peptide Sciences
• •Pricing: Among the more competitive verified suppliers in the market
• •Read the full review: PureRawz Review 2026

5. Peptide Pros — Premium Quality Positioning

Peptide Pros occupies the premium tier of the US market with a smaller but rigorously curated catalog. For research applications where compound quality is the primary variable and price is secondary, Peptide Pros is a strong candidate.

• •Testing: Rigorous independent testing with detailed per-batch COA
• •Catalog: Selective, focused on high-demand research compounds
• •Community reputation: Consistently positive in quality-focused discussions
• •Read the full review: Peptide Pros Review 2026

6. Iron Mountain Labz — Solid Mid-Tier Option

Iron Mountain Labz offers a competitive middle-ground option with solid testing documentation and a reasonable catalog breadth. Appropriate for researchers seeking verified quality without premium pricing.

• •Testing: Third-party COA documentation
• •Pricing: Mid-range
• •Read the full review: Iron Mountain Labz Review 2026

Suppliers to Approach With Extra Caution

Not all suppliers that absorbed the post-Peptide Sciences market share carry equivalent track records:

• •Swiss Chems received an FDA warning letter. Operations continue, but regulatory risk is elevated.
• •Paradigm Peptides faced a federal prosecution case and product safety concerns — detailed in our 2026 review.
• •Amino Asylum experienced an FDA warehouse raid. Currently operating but with heightened compliance uncertainty.

For a current snapshot of quality data across all tracked suppliers, use our Peptide Supplier Comparison Tool.

---

How to Compare Peptide Suppliers: A Systematic Framework

With dozens of suppliers now competing for the market displaced by the Peptide Sciences closure, price comparison alone is insufficient — and potentially misleading. Use this framework for systematic evaluation:

1. Independent Third-Party COA (Non-Negotiable)

A legitimate COA must be issued by an accredited independent laboratory — not the supplier's own in-house testing team. Key verification points:

• •Lab accreditation: ISO/IEC 17025 certification or equivalent. You should be able to independently verify the lab exists.
• •Lot number matching: The COA lot number should correspond exactly to the product batch you're ordering. Generic, undated, or single-COA-for-all-inventory approaches are significant red flags.
• •HPLC purity: ≥98% for most research peptides; higher-grade compounds should clear 99%+
• •Mass spectrometry confirmation: MS data confirms molecular identity, not just purity percentage
• •Endotoxin testing: Critical for injectable research applications — bacterial endotoxins significantly confound experimental results and can invalidate entire protocols

For a detailed walkthrough of how to read and interpret a COA, see our Complete COA Interpretation Guide.

2. Price as a Quality Signal

Pricing anomalies deserve scrutiny. A supplier offering a compound at 40-60% below market rate is not necessarily a bargain. Common explanations include:

• •Degraded or counterfeit product: Suppliers unable to sell legitimate product at market rates sometimes fill inventory with lower-quality or mislabeled compounds
• •Opportunistic Peptide Sciences inventory: Some vendors may be selling stockpiled inventory from the closed company without current quality verification
• •New entrant discounting: Post-closure entrants with no verification history often discount aggressively to capture displaced customers

Use our price comparison tool to benchmark current pricing across verified suppliers and surface anomalies worth investigating.

3. Community Track Record

r/Peptides, Eroids, and Peptides.SO reviews provide longitudinal quality signals no amount of marketing can replicate. Key pattern analysis principles:

• •Prioritize consistency over time, not review volume — a few hundred reviews spanning 3+ years outweighs thousands of reviews from the past 90 days
• •Weight negative resolution heavily — how a supplier handles problems (shipping delays, quality inconsistencies, wrong products) reveals operational integrity far more than positive testimonials
• •Watch for sudden post-closure review spikes — opportunistic vendors frequently run review campaigns after competitor shutdowns

4. Regulatory Posture

Suppliers operating cautiously in the 2026 regulatory environment typically remove or clearly label FDA-adjacent compounds, maintain transparent research-only disclaimers, and don't aggressively market GLP-1 analogs identical to approved drugs. Conservative compliance posture reduces shutdown risk — the lesson that Peptide Sciences' closure made undeniable.

5. Cold-Chain Shipping Practices

Many peptides degrade during transit without active temperature management. Reliable suppliers use ice packs or dry ice for temperature-sensitive compounds, insulated packaging, and clearly stated shipping policies for warm-weather shipping windows. Always confirm a new supplier's cold-chain protocol before your first order.

For a complete buyer's guide covering all evaluation criteria, see our Complete Peptide Supplier Buyer Guide.

---

Free Research Tools on Peptides.SO

Beyond supplier comparison, Peptides.SO provides free tools that make ongoing peptide research more efficient:

• •Price Comparison Tool: Real-time pricing across verified suppliers for common research compounds — updated continuously
• •Peptide Dosing Calculator: Calculate dosing with unit conversion, reconstitution math, and schedule planning
• •Reconstitution Guide + Calculator: Step-by-step reconstitution protocol with interactive calculator for BAC water ratios
• •Stack Builder: Build and evaluate research stacks using the Peptides.SO stack library and community data
• •Half-Life Reference Guide: Complete half-life reference with calculator for scheduling research protocols
• •Cost Per Milligram Calculator: Calculate true compound value across suppliers accounting for concentration and vial size differences — essential for cross-supplier comparisons

---

Frequently Asked Questions

What happened to Peptide Sciences?

Peptide Sciences shut down voluntarily on March 6, 2026, issuing a brief farewell message with no explanation, no refund process, and no forwarding information. The closure coincided with a period of intense FDA regulatory pressure on the US research peptide market — particularly enforcement targeting GLP-1 analog suppliers — though no direct causal connection has been publicly confirmed by the company.

Is Peptide Sciences still operating?

No. Peptide Sciences permanently closed on March 6, 2026. Any site currently claiming to sell Peptide Sciences products is either fraudulent or attempting to sell unverified old inventory from the closed company. Neither is a trustworthy source.

Are there scam sites impersonating Peptide Sciences?

Yes. Confirmed impersonator sites surfaced within days of the closure. Do not enter payment information on any site claiming to be Peptide Sciences. Verify all unfamiliar vendors through multiple independent community sources before any purchase.

What are the best alternatives to Peptide Sciences?

Among US-based suppliers with established verification records, Paramount Peptides (12+ years operating history), Core Peptides, and Direct Peptides US are reasonable starting points. Use Peptides.SO's supplier comparison tool to evaluate current pricing and quality data across the full verified supplier list.

How do I verify a peptide supplier is legitimate?

Start with the COA: confirm it is issued by a named, independently verifiable ISO/IEC 17025-accredited lab, includes lot-specific data (not generic batch results), and shows HPLC purity ≥98% with mass spectrometry confirmation. Then cross-reference with community forums (r/Peptides, Eroids) for longitudinal track records. Prioritize suppliers with at least 12-18 months of consistent community data before the current market disruption period.

Should I trust suppliers that appeared after Peptide Sciences closed?

Exercise extra caution with any vendor whose primary community history begins after March 2026. The Peptide Sciences closure created a vacuum that inevitably attracts both legitimate new entrants and opportunistic actors. For any vendor with less than 12 months of community history, budget for independent HPLC testing on your first order before relying on them for ongoing research.

Why did so many peptide suppliers receive FDA warning letters?

The FDA enforcement wave of 2025-2026 focused specifically on suppliers selling research chemicals chemically identical to FDA-approved drugs — primarily GLP-1 analogs like semaglutide and tirzepatide — without a valid NDA. New 2026 legislation explicitly codified this prohibition. Suppliers with GLP-1-heavy catalogs faced the highest enforcement risk, and the broader market experienced collateral pressure as the FDA demonstrated willingness to take action at scale.

What happened to pending Peptide Sciences orders?

No formal refund or fulfillment process was announced. Researchers who had pending orders at the time of closure had no official recourse from the company. Some reported chargebacks through credit card providers as the available remedy. This outcome underscores the value of maintaining backup supplier relationships and not pre-purchasing large quantities from any single vendor.

---

The Bottom Line

The Peptide Sciences closure was the single largest disruption the US research peptide market has experienced in recent memory. With an estimated $7.4 million in monthly revenue evaporating overnight, the displacement effect on the research community was substantial — and the market vacuum attracted both legitimate established suppliers and opportunistic entrants of highly variable quality.

The researchers best positioned after this disruption were those who had already adopted diversified procurement strategies, maintained COA documentation, and engaged with independent quality data rather than relying on any single supplier's brand reputation.

Use the supplier reviews, price comparison data, and quality tracking tools on Peptides.SO to build a vendor portfolio grounded in verifiable evidence — not brand loyalty in a market that, as Peptide Sciences demonstrated, can change overnight without warning.

Disclaimer: All content on Peptides.SO is for educational and research purposes only. Research peptides are not approved for human use. Always consult applicable regulations in your jurisdiction before purchasing or using research chemicals.